HCA250117P280000
- 1.05
- +0.40+61.54%
HCA Healthcare Newsroom
Optimistic Outlook and Buy Rating for HCA Healthcare Driven by Strategic Initiatives and Market Dynamics
HCA Healthcare Price Target Cut to $355.00/Share From $406.00 by Morgan Stanley
HCA Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $319
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $355
HCA Healthcare Analyst Ratings
JP Morgan Assumes HCA Healthcare at Neutral, Announces Price Target of $380
Goldman Sachs Adjusts Price Target on HCA Healthcare to $319 From $359, Maintains Neutral Rating
HCA Healthcare (HCA) Was Downgraded to a Sell Rating at Wells Fargo
J.P. Morgan Maintains HCA Healthcare(HCA.US) With Hold Rating, Raises Target Price to $380
HCA Healthcare Cut to Underweight From Equal-Weight by Wells Fargo
Wells Fargo Downgrades HCA Healthcare(HCA.US) to Sell Rating, Cuts Target Price to $320
Wells Fargo Downgrades HCA Healthcare to Underweight From Equalweight, Adjusts Price Target to $320 From $400
HCA Healthcare Analyst Ratings
Raymond James Downgrades HCA Healthcare(HCA.US) to Hold Rating
HCA Healthcare Downgraded to Market Perform From Outperform at Raymond James
BofA Securities Maintains HCA Healthcare(HCA.US) With Buy Rating
HCA Healthcare Is Maintained at Overweight by Barclays
HCA Healthcare Analyst Ratings
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Cuts Target Price to $392